Perspective Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
144
3
4
4/A
424B3
424B5
8-A12B
8-A12G
8-K
8-K/A
AW
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10K
POS AM
POS EX
POSASR
PRE 14A
PREM14A
REGDEX
REGDEX/A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-069301 | May 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-061994 | May 1, 2025 | — |
| 8-K | 8-K | 0000950170-25-059557 | Apr 29, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-054777 | Apr 16, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-054776 | Apr 16, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-053023 | Apr 11, 2025 | — |
| EFFECT | — | 9999999995-25-001029 | Apr 8, 2025 | — |
| POS AM | POS AM | 0000950170-25-051243 | Apr 4, 2025 | — |
| 4 | 4 | 0000950170-25-048691 | Apr 1, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048696 | Apr 1, 2025 | Mar 28, 2025 |
| 4 | 4 | 0000950170-25-048698 | Apr 1, 2025 | Mar 28, 2025 |
| 4 | 4 | 0000950170-25-048775 | Apr 1, 2025 | Mar 28, 2025 |
| 10-K/A | 10-K/A | 0000950170-25-046758 | Mar 28, 2025 | Dec 31, 2024 |
| 10-K | 10-K | 0000950170-25-045242 | Mar 26, 2025 | Dec 31, 2024 |
| POS AM | POS AM | 0000950170-25-045432 | Mar 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-045227 | Mar 26, 2025 | — |
| S-8 | S-8 | 0000950170-25-045277 | Mar 26, 2025 | — |
| POSASR | POSASR | 0000950170-25-045209 | Mar 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-039826 | Mar 17, 2025 | — |
| 4 | 4 | 0000950170-25-033662 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033665 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033649 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033675 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033614 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033626 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-033637 | Mar 5, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0000950170-25-031324 | Mar 4, 2025 | Mar 3, 2025 |
| SCHEDULE 13G/A | — | 0001274173-25-000052 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-001388 | Feb 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-012317 | Feb 3, 2025 | — |
| 8-K | 8-K | 0000950170-25-008603 | Jan 24, 2025 | — |
| 8-K | 8-K | 0000950170-25-004595 | Jan 13, 2025 | — |
| 3 | 3 | 0000950170-25-002923 | Jan 7, 2025 | Jan 6, 2025 |
| 4 | 4 | 0000950170-25-002927 | Jan 7, 2025 | Jan 6, 2025 |
| 8-K | 8-K | 0000950170-25-001712 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-24-134067 | Dec 6, 2024 | Dec 4, 2024 |
| 4 | 4 | 0000950170-24-133355 | Dec 4, 2024 | — |
| 8-K | 8-K | 0000950170-24-133062 | Dec 4, 2024 | Dec 3, 2024 |
| 4/A | 4/A | 0000950170-24-133347 | Dec 4, 2024 | Nov 25, 2024 |
| 4/A | 4/A | 0000950170-24-133351 | Dec 4, 2024 | Nov 25, 2024 |
| 4 | 4 | 0000950170-24-131250 | Nov 27, 2024 | Nov 25, 2024 |
| 4 | 4 | 0000950170-24-131251 | Nov 27, 2024 | Nov 25, 2024 |
| 4 | 4 | 0000950170-24-130754 | Nov 26, 2024 | Nov 25, 2024 |
| 8-K | 8-K | 0000950170-24-129487 | Nov 21, 2024 | — |
| 8-K | 8-K | 0000950170-24-127384 | Nov 15, 2024 | — |
| SC 13G | — | 0000919574-24-006777 | Nov 14, 2024 | — |
| SC 13G | JANUS NEW | 0001274173-24-000094 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-045828 | Nov 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-125353 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-125399 | Nov 12, 2024 | Sep 30, 2024 |